vomiting on tirzepatide Common side effects of may include nausea, vomiting, diarrhea, constipation, upper abdominal discomfort, and abdominal pain Tirzepatide Nausea and Vomiting

It belongs to a particular peptide, formulation, route, dose and clinical endpoint

Case ID: 4946 Individual results may vary

GLP-1RA exenatide administered once a week decreased heavy drinking days and total alcohol consumption, but only for a subset of participants with body mass index (BMI) over 30 19,20

Many patients find motivation in seeing steady improvement

Special Population Considerations Certain populations may need modified protocols

A large cardiovascular outcomes trial found that higher proportions of tirzepatide recipients reported vomiting, diarrhea, and nausea compared to those taking a selective GLP-1RA